Canopy Growth (TSX:WEED) Smoked on Earnings: Should You Buy on Weakness?

Should investors buy Canopy Growth Corp (TSX:WEED)(NYSE:CGC) on its recent post-earnings dip? Or is it time to take profits for good?

| More on:

Don’t say you weren’t warned!

Canopy Growth (TSX:WEED)(NYSE:CGC) got clobbered 7.6% on Friday following the reveal of a weaker-than-expected quarterly report that showed a big loss together with swelling operating expenses. Fellow Fool contributor Karen Thomas did a top-notch job of reviewing the results. In this piece, we’ll try to determine whether it still makes sense for the average Canadian investor to hold shares of the marijuana giant as it loses steam.

You need to spend money to make money, right?

Canopy CEO Bruce Linton’s tone shouldn’t have come as a surprise to investors. Every time Canopy reports a number that’s deep in the red, Linton shrugs it off and provides commentary on his views of the longer-term picture and why near-term losses aren’t a big deal in the grander scheme of things.

“You need to use that capital to build scale. And we did,” said Linton in Canopy’s conference call.

To Linton, it’s all about short-term pain for long-term gain, and with his foot on the gas, he’ll likely have no problem telling prospective marijuana investors to “go buy a bank” if a dividend or lower capital spending is what they seek from his hyper-growth firm.

In terms of profitability, Linton also told analysts that Canopy “would have been a nice, tidy little company, probably quite profitable” if the firm “had stayed” in its high-margin state.

Linton sees margins racing higher at year-end as investments begin paying off, while higher-margin edibles sales start coming into the equation. With Canopy readying to jump on the edibles bandwagon later this year, many investors are wondering if big-name cannabis kings like Canopy could stand to experience another exponential rally.

Should you take Linton’s word for it?

While I am a fan of Linton’s aggressive spending, I also think Canopy has the least upside relative to its peers for many reasons that I outlined in past pieces. Moreover, legal edibles sales will be an industry-wide boon to margins, and although Canopy is getting locked and loaded, so too are other pot players that’ve posted better margins of late.

Sure, Canopy has a deep-pocketed dance partner in its corner and may be perceived as one of the “safer” bets in the space, but investors have to remember that Canopy trades at nearly 80 times sales, making it one of the most expensive stocks on the planet. Canopy could halve several times over and still be considered “expensive” through the eyes of fundamental analysts. By comparison, Canopy makes Shopify, one of Canada’s highest-flying stocks, look like a cheap stock with its hefty 30 times sales multiple.

I can’t say I’m an advocate of buying shares of Canopy after its latest dip. We’re almost a year into legalization, and the “edibles tailwind” that some investors are growing excited about may not be enough to reverse the negative momentum faced by the industry, especially should Canada face an unexpected cannabis oversupply problem going into year-end.

Canopy is a premier cannabis player, but it’s also priced like one. The recent 7.6% drop in Canopy shares would have me worried sick to be an investor.

Stay hungry. Stay Foolish.

Fool contributor Joey Frenette has no position in any of the stocks mentioned. Tom Gardner owns shares of Shopify. The Motley Fool owns shares of Shopify and Shopify. Shopify is a recommendation of Stock Advisor Canada.

More on Cannabis Stocks

runner checks her biodata on smartwatch
Cannabis Stocks

Average TFSA and RRSP Balances at Age 45: Are You on Par?

Most 45-year-olds have less than $100,000 combined in their TFSA and RRSP. Here's how TerrAscend could help you close the…

Read more »

Yellow caution tape attached to traffic cone
Cannabis Stocks

2 Risky Stocks That Could Send Your $100,000 Investment to $0

Cannabis stocks look risky because price wars, dilution, and regulation can turn one weak quarter into a long drawdown.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

My Biggest Investing Regret in 2025 Was Buying This Stock

Canopy Growth is a cautionary reminder to buy businesses, not headlines, especially in hype-driven sectors like cannabis.

Read more »

Yellow caution tape attached to traffic cone
Cannabis Stocks

2 Popular Stocks That Could Wipe Out a $100,000 Nest Egg

Aurora Cannabis (TSX:ACB) is one stock that could wipe out your nest egg.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Here’s Why I Wouldn’t Touch Canopy Growth Stock With a 10-Foot Pole

Down almost 99% from all-time highs, Canopy Growth is a beaten-down cannabis stock that remains a high-risk investment in 2026.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

2 Stocks That Could Turn $100,000 Into $0 Faster Than You Think

Canopy Growth and Plug Power are two unprofitable stocks that remain high-risk investments for shareholders in 2026.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Will Canopy Growth Keep the Losing Streak Going in 2026?

Canopy Growth Corp (TSX:WEED) was one of the market's biggest losers in 2025.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

TFSA Investors: An Undervalued Cannabis Stock You Can Buy for $500 Right Now

Down almost 70% from all-time highs, Curaleaf is a TSX cannabis stock that trades at an attractive valuation in December…

Read more »